Based on a recent TIME magazine interview with President-Elect Donald Trump, the pharmaceutical and life science industries may expect to find coal in their Christmas stocking, and tougher pricing constraints in 2017.
“I’m going to bring down drug prices,” Mr. Trump said, quoted on the TIME website naming him Person of the Year. “I don’t like what’s happened with drug prices.”
As CNN put it, “Trump put the entire drug industry on notice.
In fact, Donald Trump’s campaign website talked about drug importation as one potential tactic consumers could potentially use to bring down their household prescription drug costs.
The issue of drug pricing hit popular culture status in 2016 based on the EpiPen pricing story, on top of the past two years’ stories of Gilead’s Hepatitis C drug pricing(for Harvoni and Sovaldi), and the demonization of Martin Shkreli of Turing Pharmaceuticals, called, “The Bad Boy of Pharma” by the New York Times one year ago.